#ADA2017: On Visual Learning, Standardization, Data And More Data
Executive Summary
The 77th American Diabetes Association conference, held June 9-13 in San Diego, attracted more than 16,000 attendees from 120 countries and featured more than 2,500 presentations. Medtech Insight had its ear close to the ground at the meeting, posting Tweets on major clinical trial data updates, as well as insights on the latest trends and innovations in the field. This article rounds up the best of the Tweets and includes updates from key diabetes management players including Abbott, Medtronic, Senseonics and Dexcom.
You may also be interested in...
Market Intel: Voyage Into Point-Of-Care Testing Gets Deeper
Diagnostic testing is increasingly moving from centralized laboratories into pharmacies, physicians' offices, hospitals and directly to consumers as part of the transition to value-based care with its focus on providing quality care at a lower cost. Point-of-care testing (POCT) – and what it means for the future of health-care delivery, health-care providers and creators of innovative technologies joining forces to satisfy consumers' growing appetite for convenient and rapid testing – took centerstage at the recent AACC Annual Meeting in San Diego. This feature takes a closer look at the increasing migration of POCT into the retail arena, specifically pharmacies, to support primary-care providers, along with its challenges. It also highlights emerging trends and technologies, including presentations of the "Star Trek-like" innovations from the Qualcomm Tricorder XPrize competition winners that are bound to disrupt the landscape of direct-to-consumer testing. We also provide expert opinions of the pros and cons of bringing POC services closer to consumers.
Abbott Gains US Approval For Pro Version Of Flash Glucose System
The FreeStyle Libre Pro is intended to provide health-care providers with an easy-to-read visual summary of a diabetic patient's glucose data. Abbott has also filed for approval with FDA for a consumer-targeted version of the device.
US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G
The hybrid closed-loop automated insulin delivery system, the first closed-loop system approved anywhere in the world, automatically monitors glucose and provides appropriate basal insulin doses in people with type 1 diabetes.